Kynam Capital Management, LP 13D/13G Filings for Cogent Biosciences, Inc. (COGT)

Kynam Capital Management, LP 13D and 13G filings for Cogent Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
12:24 pm
Purchase		 2024-09-30 13G Cogent Biosciences, Inc.
COGT		 Kynam Capital Management, LP 9,239,731
8.360%		 3,384,965increase
(+57.82%)		 Filing
2024-02-14
12:51 pm
Purchase		 2023-12-31 13G Cogent Biosciences, Inc.
COGT		 Kynam Capital Management, LP 5,854,766
6.800%		 5,854,766increase
(New Position)		 Filing